Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Voisin, Veronique ^a,b   Legault, Philippe ^a   Ospina, Diana Paulina Salazar ^a   Ben David, Yaacov ^b   Rassart, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ERYTHROLEUKEMIA; ERYTHROPOIESIS; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC IDENTIFICATION; GRAFFI MURINE RETROVIRUS; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; MEGAKARYOBLASTIC LEUKEMIA; MEGAKARYOPOIESIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DNA CELL DNA INTERACTION; ACUTE MEGAKARYOCYTIC LEUKEMIA; ANIMAL; DISEASE MODEL; GENETICS; ISOLATION AND PURIFICATION; MURINE LEUKEMIA VIRUS; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

MURINAE; MUS;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA VIRUS, MURINE; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MICE; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS INTEGRATION;

EID: 77649316005     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-2     Document Type: Article

References (80)

1. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick C Sultan, Ann Intern Med 1985 103 3 460 462
2. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick C Sultan, British journal of haematology 1976 33 4 451 458
3. Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases. A Colita A Belhabri Y Chelghoum C Charrin D Fiere X Thomas, Annals of Oncology 2001 12 451 455
4. Erythroleukaemia in the north of England: a population based study. AW Wells N Bown MM Reid PJ Hamilton GH Jackson PR Taylor, Journal of Clinical Pathology 2001 54 608 612
5. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. A Domingo-Claros I Larriba M Rozman D Irriguible T Vallespi A Aventin R Ayats F Milla F Sole L Florensa, et al. Haematologica 2002 87 2 148 153
6. Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children. Rogelio Paredes-Aguilera LR-GNL-SRAT, American Journal of Hematology 2003 73 71 80
7. Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). L Garderet M Labopin NC Gorin E Polge A Baruchel G Meloni J Ortega J Vossen D Bunjes G Leverger, et al. Blood 2005 105 1 405 409
8. Erythroleukemia: a need for a new definition. S Park F Picard F Dreyfus, Leukemia 2002 16 8 1399 1401
9. Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias. S Linari AM Vannucchi S Ciolli F Leoni R Caporale A Grossi G Pagliai V Santini F Paoletti PR Ferrini, British journal of haematology 1998 102 5 1335 1337
10. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. N Debili L Coulombel L Croisille A Katz J Guichard J Breton-Gorius W Vainchenker, Blood 1996 88 4 1284 1296
11. Characterization of mouse clonogenic megakaryocyte progenitors. TN Nakorn T Miyamoto IL Weissman, Proceedings of the National Academy of Sciences of the United States of America 2003 100 1 205 210
12. Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus. V Voisin C Barat T Hoang E Rassart, J Virol 2006 80 8 4026 4037
13. FlexArray: A statistical data analysis software for gene expression microarrays. Genome Quebec, Montreal, Canada, URL http://genomequebec.mcgill.ca/ FlexArray. M Blazejczyk M Miron R Nadon, 2007
14. Cluster analysis and display of genome-wide expression patterns. MB Eisen PT Spellman PO Brown D Botstein, Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 14863 14868
15. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. P Tamayo D Slonim J Mesirov Q Zhu S Kitareewan E Dmitrovsky ES Lander TR Golub, Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2907 2912
16. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5116 5121
17. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence. KS Wong YJ Li J Howard Y Ben-David, Oncogene 1999 18 40 5525 5534
18. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. H Mikkers J Allen P Knipscheer L Romeijn A Hart E Vink A Berns, Nature genetics 2002 32 1 153 159
19. Erythroid and megakaryoblastic leukemias induced by the murine retrovirus Graffi Gene expression profiling MOE 430.2 GEO:GSE12581 Additional analyses and Downloadable excel files URL: http://www.biomed.uqam.ca/rassart/microarray. html. V Voisin E Rassart, 2009
20. Histologic and molecular characterizations of megakaryocytic leukemia in mice. X Hao MS Shin JX Zhou CH Lee CF Qi Z Naghashfar JW Hartley TN Fredrickson JM Ward HC Morse, Leuk Res 2006 30 4 397 406 Epub 2005 Oct 2010.
21. Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation. I Hamlett J Draper J Strouboulis F Iborra C Porcher P Vyas, Blood 2008 112 7 2738 2749
22. EVI1 and hematopoietic disorders: history and perspectives. G Nucifora L Laricchia-Robbio V Senyuk, Gene 2006 368 1 11
23. The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity. A Kilbey H Alzuherri J McColl C Cales J Frampton C Bartholomew, British journal of haematology 2005 130 6 902 911 10.1111/j.1365-2141.2005.05709.x 16156860
24. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. HM Bond M Mesuraca E Carbone P Bonelli V Agosti N Amodio G De Rosa M Di Nicola AM Gianni MA Moore, et al. Blood 2004 103 6 2062 2070 10.1182/blood-2003-07-2388 14630787
25. Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia. KE Hentges KC Weiser T Schountz LS Woodward HC Morse MJ Justice, Oncogene 2005 24 7 1220 1230 10.1038/sj.onc.1208243 15580294
26. Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma. L Hu JS Sham D Xie JM Wen WS Wang Y Wang XY Guan, Cancer Lett 2007 252 1 36 42 10.1016/j.canlet. 2006.12.003 17215076
27. N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. M van Lohuizen M Breuer A Berns, Embo J 1989 8 1 133 136 2653809
28. N-myc can cooperate with ras to transform normal cells in culture. GD Yancopoulos PD Nisen A Tesfaye NE Kohl MP Goldfarb FW Alt, Proc Natl Acad Sci USA 1985 82 16 5455 5459 10.1073/pnas.82.16.5455 3860871
29. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. JD Cheng M Valianou AA Canutescu EK Jaffe HO Lee H Wang JH Lai WW Bachovchin LM Weiner, Mol Cancer Ther 2005 4 3 351 360 15767544
30. Deregulation of common genes by c-Myc and its direct target, MT-MC1. KR Rogulski DE Cohen DL Corcoran PV Benos EV Prochownik, Proceedings of the National Academy of Sciences of the United States of America 2005 102 52 18968 18973 10.1073/pnas.0507902102 16365299
31. Role of c-Fes in normal and neoplastic hematopoiesis. KE Yates JC Gasson, Stem cells (Dayton, Ohio) 1996 14 1 117 123 10.1002/stem.140117 8820957
32. Cellular levels of mRNA from c-myc, c-myb and c-fes onc-genes in normal myeloid and erythroid precursors of human bone marrow: an in situ hybridization study. G Emilia A Donelli S Ferrari U Torelli L Selleri P Zucchini L Moretti D Venturelli G Ceccherelli G Torelli, British journal of haematology 1986 62 2 287 292 10.1111/j.1365-2141.1986.tb02931.x 3947550
33. Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. AH Fox C Liew M Holmes K Kowalski J Mackay M Crossley, The EMBO journal 1999 18 10 2812 2822 10.1093/emboj/18.10.2812 10329627
34. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. R Hromas A Orazi RS Neiman R Maki C Van Beveran J Moore M Klemsz, Blood 1993 82 10 2998 3004 8219191
35. Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1/Spi-1 in UT7-Mpl cells. A Doubeikovski G Uzan Z Doubeikovski MH Prandini F Porteu S Gisselbrecht I Dusanter-Fourt, The Journal of biological chemistry 1997 272 39 24300 24307 10.1074/jbc.272.39.24300 9305885
36. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration. C Denicourt E Edouard E Rassart, J Virol 1999 73 5 4439 4442 10196342
37. Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2. Z Chen M Hu RA Shivdasani, Blood 2007 109 4 1451 1459 10.1182/blood-2006-08-038901 17047147
38. Platelets express functional Toll-like receptor-4. G Andonegui SM Kerfoot K McNagny KV Ebbert KD Patel P Kubes, Blood 2005 106 7 2417 2423 10.1182/blood-2005-03-0916 15961512
39. Evidence of Toll-like receptor molecules on human platelets. F Cognasse H Hamzeh P Chavarin S Acquart C Genin O Garraud, Immunology and cell biology 2005 83 2 196 198 10.1111/j.1440-1711.2005.01314.x 15748217
40. Global regulation of erythroid gene expression by transcription factor GATA-1. JJ Welch JA Watts CR Vakoc Y Yao H Wang RC Hardison GA Blobel LA Chodosh MJ Weiss, Blood 2004 104 10 3136 3147 10.1182/blood-2004-04-1603 15297311
41. EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts. J Fang M Menon W Kapelle O Bogacheva O Bogachev E Houde S Browne P Sathyanarayana DM Wojchowski, Blood 2007 110 7 2361 2370 10.1182/blood-2006-12-063503 17548578
42. Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. P Sathyanarayana MP Menon O Bogacheva O Bogachev K Niss WS Kapelle E Houde J Fang DM Wojchowski, Blood 2007 110 2 509 518 10.1182/blood-2006-11- 056465 17403918
43. EPO receptor circuits for primary erythroblast survival. P Sathyanarayana A Dev J Fang E Houde O Bogacheva O Bogachev M Menon S Browne A Pradeep C Emerson, et al. Blood 2008 111 11 5390 5399 10.1182/blood-2007-10-119743 18349318
44. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. F Dreyfus B Sola S Fichelson P Varlet M Charon P Tambourin F Wendling S Gisselbrecht, Leukemia 1990 4 8 590 594 2143796
45. SSX2IP: an emerging role in cancer. A Breslin FA Denniss BA Guinn, Biochemical and biophysical research communications 2007 363 3 462 465 10.1016/j.bbrc.2007.09.052 17904521
46. Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. M Ren G Xu J Zeng C De Lemos-Chiarandini M Adesnik DD Sabatini, Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6187 6192 10.1073/pnas.95.11.6187 9600939
47. Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. CJ Westlake JR Junutula GC Simon M Pilli R Prekeris RH Scheller PK Jackson AG Eldridge, Proceedings of the National Academy of Sciences of the United States of America 2007 104 4 1236 1241 10.1073/pnas.0610500104 17229837
48. Rab11a differentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells. D Palmieri A Bouadis R Ronchetti MJ Merino PS Steeg, Breast cancer research and treatment 2006 100 2 127 137 10.1007/s10549-006-9244-6 16791477
49. SRC-3/AIB1: transcriptional coactivator in oncogenesis. J Yan SY Tsai MJ Tsai, Acta pharmacologica Sinica 2006 27 4 387 394 10.1111/j.1745-7254.2006. 00315.x 16539836
50. RTCGD: retroviral tagged cancer gene database. K Akagi T Suzuki RM Stephens NA Jenkins NG Copeland, Nucleic acids research 2004 32 Database 523 527 10.1093/nar/gkh013 14681473
51. Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. D Malin IM Kim E Boetticher TV Kalin S Ramakrishna L Meliton V Ustiyan X Zhu VV Kalinichenko, Molecular and cellular biology 2007 27 7 2486 2498 10.1128/MCB.01736-06 17261592
52. The Icsbp locus is a common proviral insertion site in mature B-cell lymphomas/plasmacytomas induced by exogenous murine leukemia virus. SL Ma AB Sorensen S Kunder KD Sorensen L Quintanilla-Martinez DW Morris J Schmidt FS Pedersen, Virology 2006 352 2 306 318 10.1016/j.virol.2006.05.006 16780917
53. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2. Y Cheli S Kanaji B Jacquelin M Chang DJ Nugent TJ Kunicki, Biochimica et biophysica acta 2007 1769 9-10 546 558 17669516
54. Origins of leukaemia in children with Down syndrome. JK Hitzler A Zipursky, Nat Rev Cancer 2005 5 1 11 20 10.1038/nrc1525 15630411
55. Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2. K Kitajima M Tanaka J Zheng H Yen A Sato D Sugiyama H Umehara E Sakai T Nakano, Blood 2006 107 5 1857 1863 10.1182/blood-2005-06-2527 16254139
56. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. G Chinnadurai, Molecular cell 2002 9 2 213 224 10.1016/S1097- 2765(02)00443-4 11864595
57. Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos. K Maki T Yamagata T Asai I Yamazaki H Oda H Hirai K Mitani, Blood 2005 106 6 2147 2155 10.1182/blood-2004-11-4330 15914564
58. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin. K Terui Y Takahashi J Kitazawa T Toki M Yokoyama E Ito, The Tohoku journal of experimental medicine 2000 192 4 259 273 10.1620/tjem.192.259 11286316
59. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. H Yuasa Y Oike A Iwama I Nishikata D Sugiyama A Perkins ML Mucenski T Suda K Morishita, The EMBO journal 2005 24 11 1976 1987 10.1038/sj.emboj.7600679 15889140
60. Inhibition of angiogenesis in human glioma cell lines by antisense RNA from the soluble guanylate cyclase genes, GUCY1A3 and GUCY1B3. M Saino T Maruyama T Sekiya T Kayama Y Murakami, Oncology reports 2004 12 1 47 52 15201957
61. Induction of platelet formation from megakaryocytoid cells by nitric oxide. E Battinelli SR Willoughby T Foxall CR Valeri J Loscalzo, Proceedings of the National Academy of Sciences of the United States of America 2001 98 25 14458 14463 10.1073/pnas.241427398 11734646
62. The lipoprotein receptor-related protein-1 (LRP) adapter protein GULP mediates trafficking of the LRP ligand prosaposin, leading to sphingolipid and free cholesterol accumulation in late endosomes and impaired efflux. RS Kiss Z Ma K Nakada-Tsukui E Brugnera G Vassiliou HM McBride KS Ravichandran YL Marcel, The Journal of biological chemistry 2006 281 17 12081 12092 10.1074/jbc. M600621200 16497666
63. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. MJ Kiel OH Yilmaz T Iwashita OH Yilmaz C Terhorst SJ Morrison, Cell 2005 121 7 1109 1121 10.1016/j.cell.2005.05. 026 15989959
64. Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. M Nakai M Fujita M Waragai S Sugama J Wei H Akatsu C Ohtaka-Maruyama H Okado M Hashimoto, Biochemical and biophysical research communications 2007 358 1 104 110 10.1016/j.bbrc.2007.04. 108 17475220
65. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. CR Scherzer JA Grass Z Liao I Pepivani B Zheng AC Eklund PA Ney J Ng M McGoldrick B Mollenhauer, et al. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10907 10912 10.1073/pnas.0802437105 18669654
66. Latent Transforming Growth Factor - binding Protein 2 Is an Adhesion Protein for Melanoma Cells. P Vehvilainen M Hyytiainen J Keski-Oja, The Journal of Biochemical Chemistry 2003 278 24705 24713
67. The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. R Mattera YC Tsai AM Weissman JS Bonifacino, The Journal of biological chemistry 2006 281 10 6874 6883 10.1074/jbc.M509939200 16407276
68. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. J Kalesnikoff EJ Rios C-C Chen S Nakae BA Zabel EC Butcher M Tsai S-Y Tam SJ Galli, Proceedings of the National Academy of Sciences of the United States of America 2006 103 2659 2664 10.1073/pnas.0511191103 16533754
69. Platelets: signaling cells in the immune continuum. AS Weyrich GA Zimmerman, Trends in immunology 2004 25 9 489 495 10.1016/j.it.2004.07.003 15324742
70. The emerging role of platelets in adaptive immunity. BD Elzey DL Sprague TL Ratliff, Cellular immunology 2005 238 1 1 9 10.1016/j.cellimm.2005.12.005 16442516
71. The role of platelet CD154 in the modulation in adaptive immunity. DL Sprague JM Sowa BD Elzey TL Ratliff, Immunologic research 2007 39 1-3 185 193 10.1007/s12026-007-0074-3 17917065
72. Platelets as immune cells: bridging inflammation and cardiovascular disease. P von Hundelshausen C Weber, Circulation research 2007 100 1 27 40 10.1161/01.RES.0000252802.25497.b7 17204662
73. Adhesion molecule LFA-1/ICAM-1 influences on LPS-induced megakaryocytic emperipolesis in the rat bone marrow. M Tanaka Y Aze T Fujita, Veterinary pathology 1997 34 5 463 466 10.1177/030098589703400511 9381658
74. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. C Slape H Hartung YW Lin J Bies L Wolff PD Aplan, Cancer research 2007 67 11 5148 5155 10.1158/0008-5472.CAN-07- 0075 17545593
75. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. P Ikonomi CE Rivera M Riordan G Washington AN Schechter CT Noguchi, Experimental hematology 2000 28 12 1423 1431 10.1016/S0301-472X(00) 00553-1 11146164
76. SCL: from the origin of hematopoiesis to stem cells and leukemia. E Lecuyer T Hoang, Experimental hematology 2004 32 1 11 24 10.1016/j.exphem.2003. 10.010 14725896
77. Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors. J Antonchuk CD Hyland DJ Hilton WS Alexander, Blood 2004 104 5 1306 1313 10.1182/blood-2004-04-1522 15138166
78. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. A Zeuner M Signore D Martinetti M Bartucci C Peschle R De Maria, Cancer research 2007 67 10 4767 4773 10.1158/0008-5472.CAN-06-4303 17510405
79. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. JP Bourquin A Subramanian C Langebrake D Reinhardt O Bernard P Ballerini A Baruchel H Cave N Dastugue H Hasle, et al. Proceedings of the National Academy of Sciences of the United States of America 2006 103 9 3339 3344 10.1073/pnas.0511150103 16492768
80. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia. T Toki R Kanezaki S Adachi H Fujino G Xu T Sato K Suzuki H Tauchi M Endo E Ito, Leukemia 2009 23 1 95 103 10.1038/leu.2008.267 18830255